NC-DOLE-FOOD-NC
Dole Food Company announced today that in an effort to help with the COVID-19 crisis, Dole and its associated growers have so far donated more than two million pounds of fresh produce to recipients along its supply chain, from local food banks in the U.S. to the communities in Latin America.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200416005885/en/
“The virus is ruthless, and we have seen the brutal impact it has had on people—directly to their health and their income,” stated Johan Linden, CEO of Dole Food Company. “We want to answer the needs of the communities around our operations and do what we can to strengthen them during this moment of hardship.”
Dole recognizes these donations alone will not solve the food needs issue brought on by the coronavirus, but believes that we should all do what we can to help those around us. Dole is committed to continuing these efforts during this crisis.
Vince Hall, CEO of Feeding San Diego, an organization whose mission is to connect every person facing hunger with nutritious meals, shared his comments on Dole’s actions.
“While medical providers and first responders battle the COVID-19 crisis, Feeding San Diego is battling unprecedented hunger across San Diego County. One of our most important allies in this fight is Dole Food Company, a significant employer at the Port of San Diego. Dole continues to regularly donate large amounts of nutritious fresh fruit, especially bananas, which are very popular in the community and contribute to good health. Dole is to be commended for helping Feeding San Diego take care of those in need all year round, but especially during the current health crisis.”
In addition to San Diego, Dole has made donations in other U.S. cities including New York, Philadelphia, Charlotte, Houston, Los Angeles.
In Latin America, where Dole grows its tropical fruits, such as bananas and pineapple, the crisis is also hitting hard, and the company is supporting those rural communities where food security is most at risk. In the Aguan Valley of Honduras, for example, in addition to fruit Dole is distributing household staples such as rice, beans and cooking oil to employees and local communities. Beyond food, the company is also providing masks, sanitizing gel, testing kits and other health supporting supplies. Similar support is happening for communities in Costa Rica, Ecuador, Guatemala and Colombia including the provision of over 15,000 personal hygiene kits to aid in the prevention of infection.
“As an important local employer, it is our duty to support local communities. The consequences of this crisis are just starting to be felt here and the need for social support will continue to be felt in the weeks and months to come,” stated Renato Acuña, President of Dole Fresh Fruit Latin America. “Our local foundations and those of our associated producers are actively working on the ground and on the front line of this crisis, and Dole will provide additional support as long as necessary.”
The Dale Foundation, funded by Dole and its Ecuadorian growers, is using its medical staff and facilities to get the word out to the community on the importance of COVID-19 prevention, identifying high risk citizens to help them undertake the proper care, advancing purchases of medication that can help with respiratory illness, and continuing to operate its health clinics and provide remote medical services for its patients in the agricultural community.
Dole is also supporting those working on the front lines of the crisis by donating to hospitals in various countries where it operates and working with civil authorities to provide local aid.
For example, in the U.S., Dole has joined national produce distributor PRO*ACT, and other produce partners, to bring fresh produce to the tables of healthcare workers and their families during the COVID-19 crisis. The ‘Feeding our Frontlines’ program (www.producepartners.org ) provides boxes of fresh produce for healthcare employees to take home at the end of a long shift as a way of saying “thank you” to those taking care of us."
About Dole Food Company
Dole Food Company, Inc., is one of the world’s largest producers and marketers of high-quality fresh fruit and fresh vegetables. Dole is an industry leader in many of the products it sells, as well as in nutrition education. For more information, please visit www.dole.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200416005885/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
